KFF Health News | O Zenda
Underlying the hype, outside researchers and company representatives themselves have told the FDA and Congress that there’s little evidence supporting the efficacy of these products. What studies there are give contradictory answers — and some research suggests companion-focused chatbots are “consistently poor” at managing crises. “When it comes to chatbots, we don’t have any good evidence it works,” said Charlotte Blease, a Professor at Sweden’s Uppsala University who specializes in trial design for digital health products.